Abstract
Recent studies have linked accumulation of the Gr-1 + CD11b + cell phenotype with functional immunosuppression in diverse pathological conditions, including bacterial and parasitic infections and cancer. Gr-1 + CD11b + cells were the largest population of cells present in the spleens of mice infected with sublethal doses of the Francisella tularensis live vaccine strain (LVS). In contrast, the number of T cells present in the spleens of these mice did not increase during early infection. There was a significant delay in the kinetics of accumulation of Gr-1 + CD11b + cells in the spleens of B-cell-deficient mice, indicating that B cells play a role in recruitment and maintenance of this population in the spleens of mice infected with F. tularensis. The splenic Gr-1 + CD11b + cells in tularemia were a heterogeneous population that could be further subdivided into monocytic (mononuclear) and granulocytic (polymorphonuclear) cells using the Ly6C and Ly6G markers and differentiated into antigen-presenting cells following ex vivo culture. Monocytic, CD11b + Ly6C hi Ly6G - cells but not granulocytic, CD11b + Ly6C int Ly6G + cells purified from the spleens of mice infected with F. tularensis suppressed polyclonal T-cell proliferation via a nitric oxide-dependent pathway. Although the monocytic, CD11b + Ly6C hi Ly6G - cells were able to suppress the proliferation of T cells, the large presence of Gr-1 + CD11b + cells in mice that survived F. tularensis infection also suggests a potential role for these cells in the protective host response to tularemia. © 2012, American Society for Microbiology.
Cite
CITATION STYLE
Rasmussen, J. W., Tam, J. W., Okan, N. A., Mena, P., Furie, M. B., Thanassi, D. G., … van der Veldena, A. W. M. (2012). Phenotypic, morphological, and functional heterogeneity of splenic immature myeloid cells in the host response to tularemia. Infection and Immunity, 80(7), 2371–2381. https://doi.org/10.1128/IAI.00365-12
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.